Can Opicapone be taken long-term?

Opicapone (Opicapone) belongs to a class of drugs called COMT inhibitors, which are used with other drugs (Levodopa/Carbidopa) to treat Parkinson's disease. Many people who take levodopa to treat Parkinson's disease have a problem with the levodopa wearing off between scheduled doses, which causes symptoms to return or worsen. Opicapone blocks a natural substance (COMT) that breaks down levodopa in the body. This effect helps levodopa work better and last longer.

Current clinical studies show that Opicapone is a relatively safe and effective drug that can be taken long-term. However, before using any medication, patients should consult their physician to determine whether long-term use of Opicapone is appropriate based on their physician's advice. When taking Opicapone long-term, patients need to pay close attention to the side effects and effects of the drug. Some possible side effects include nausea, headache, constipation, etc. If serious side effects occur, patients should seek medical treatment promptly and stop using the drug.

Opicapone joins the market as one of threeCOMT inhibitors designed to control end-dose motor fluctuations associated with the use of carbidopa/levodopa. Opicapone may be superior to entacapone because its pharmacokinetics permit once-daily dosing and it has shown noninferior efficacy to entacapone. Furthermore, opicapone appears to be well tolerated and associated with a reduced risk of hepatotoxicity compared with the COMT inhibitor tolcapone. Opicapone may be the first choice for patients who wish to improve compliance by reducing medication burden. Therefore, patients should appropriately reduce the dose of carbidopa/levodopa during initial use.